menu
    • menu

    Company profile for Guardant Health

    NEW Drugs in Dev: 2
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics.We believe the key to conquering cancer is unprecedented access to its molecular information throughout all stages of the disease. We are developing a solution through tests that require only a blood sample.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Guardant HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    505 Penobscot Dr. Redwood City, CA 94063
    Telephone
    Telephone
    855.698.8887
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://guardanthealth.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/guardanthealth
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Guardant Reveal Backed by Largest Stage III Colon Cancer MRD
    Guardant Reveal Backed by Largest Stage III Colon Cancer MRD

    02 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260202593149/en/Largest-Published-Study-of-Molecular-Residual-Disease-MRD-in-Stage-III-Colon-Cancer-Shows-Guardant-Reveal-Blood-Test-More-Precisely-Identifies-Risk-of-Recurrence-After-Surgery-to-Support-Timely-Treatment-Decisions

    BUSINESSWIRE
    02 Feb 2026
    Share Share
    Guardant Health to Report Q4, FY 2025 Results Feb. 19
    Guardant Health to Report Q4, FY 2025 Results Feb. 19

    29 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260129040273/en/Guardant-Health-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-19-2026

    BUSINESSWIRE
    29 Jan 2026
    Share Share
    Guardant Health Gets FDA Nod For Guardant360 CDx With BRAFTOVI
    Guardant Health Gets FDA Nod For Guardant360 CDx With BRAFTOVI

    22 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260122091904/en/Guardant-Health-Receives-FDA-Approval-for-Guardant360-CDx-as-Companion-Diagnostic-for-BRAFTOVI-encorafenib-Combination-in-Patients-with-BRAF-V600E-Mutant-Metastatic-Colorectal-Cancer

    BUSINESSWIRE
    22 Jan 2026
    Share Share
    Guardant Health, Merck Partner To Develop Cancer Therapies
    Guardant Health, Merck Partner To Develop Cancer Therapies

    19 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260119596555/en/Guardant-Health-Announces-Multi-Year-Strategic-Collaboration-Agreement-with-Merck-to-Develop-Companion-Diagnostics-and-Commercialize-New-Cancer-Therapies-Using-Guardant-Infinity-Smart-Platform

    BUSINESSWIRE
    19 Jan 2026
    Share Share
    Guardant Health Reveals 2025 Q4 And Full-Year Results
    Guardant Health Reveals 2025 Q4 And Full-Year Results

    11 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260111909115/en/Guardant-Health-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2025-Results

    BUSINESSWIRE
    11 Jan 2026
    Share Share
    Guardant Health Launches Shield Blood Test For Colorectal Cancer
    Guardant Health Launches Shield Blood Test For Colorectal Cancer

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108194386/en/Guardant-Healths-Shield-Blood-Test-for-Colorectal-Cancer-Screening-Now-Available-for-U.S.-Military-Members-and-Families

    BUSINESSWIRE
    08 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search